Literature DB >> 2725686

A conjugate of acyclovir monophosphate with lactosaminated albumin releases the phosphorylated drug in liver cells.

L Fiume1, C Busi, A Mattioli, C Spinelli, G Spinosa, A Bongini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725686     DOI: 10.1007/bf00396711

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  14 in total

1.  The metabolism of P32-labeled ribonucleotides in tissue slices and cell suspensions.

Authors:  K C LEIBMAN; C HEIDELBERGER
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

2.  Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-beta-D-arabinofuranosyladenine 5'-monophosphate.

Authors:  L Fiume; B Bassi; C Busi; A Mattioli; G Spinosa; H Faulstich
Journal:  FEBS Lett       Date:  1986-07-28       Impact factor: 4.124

3.  Conjugates of 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) with lactosaminated albumin. Characterization of the drug-carrier bonds.

Authors:  L Fiume; B Bassi; A Bongini
Journal:  Pharm Acta Helv       Date:  1988

4.  A novel method for phosphorylation of nucleosides to 5'-nucleotides.

Authors:  M Yoshikawa; T Kato; T Takenishi
Journal:  Tetrahedron Lett       Date:  1967-12       Impact factor: 2.415

5.  Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.

Authors:  P M Schwartz; J Novack; C Shipman; J C Drach
Journal:  Biochem Pharmacol       Date:  1984-08-01       Impact factor: 5.858

Review 6.  Targeting of antiviral drugs bound to protein carriers.

Authors:  L Fiume; C Busi; A Mattioli; G Spinosa
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

7.  Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

Authors:  I V Weller; V Carreno; M J Fowler; J Monjardino; D Makinen; Z Varghese; P Sweny; H C Thomas; S Sherlock
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

8.  Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.

Authors:  L Fiume; M R Cerenzia; F Bonino; C Busi; A Mattioli; M R Brunetto; E Chiaberge; G Verme
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

9.  Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat.

Authors:  L Fiume; C Busi; P Preti; G Spinosa
Journal:  Cancer Drug Deliv       Date:  1987

10.  Effect of reductive lactosamination on the hepatic uptake of bovine pancreatic ribonuclease A dimer.

Authors:  G Wilson
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.